Creative Planning United Therapeutics Corp Transaction History

Creative Planning

$106 Billion
Q1 2025

A detailed history of Creative Planning transactions in United Therapeutics Corp stock. As of the latest transaction made, Creative Planning holds 3,878 shares of UTHR stock, worth $1.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,878

Previous 4,931 21.35%

Holding current value

$1.13 Million

Previous $1.74 Million 31.28%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$304.42 - $380.78 $320,554 - $400,961	-1,053 Reduced 21.35%	3,878 $1.2 Million
Q4 2024 Feb 14, 2025	BUY	$348.66 - $410.0 $347,265 - $408,360	996 Added 25.31%	4,931 $1.74 Million
Q3 2024 Oct 11, 2024	BUY	$311.04 - $363.55 $100,154 - $117,063	322 Added 8.91%	3,935 $1.41 Million
Q2 2024 Aug 15, 2024	BUY	$228.26 - $319.04 $138,097 - $193,019	605 Added 20.11%	3,613 $1.15 Million
Q1 2024 May 10, 2024	SELL	$210.76 - $249.51 $71,236 - $84,334	-338 Reduced 10.1%	3,008 $690,000
Q4 2023 Feb 14, 2024	BUY	$214.88 - $256.94 $103,357 - $123,588	481 Added 16.79%	3,346 $735,000
Q3 2023 Nov 16, 2023	SELL	$211.82 - $248.24 $8,472 - $9,929	-40 Reduced 1.38%	2,865 $647,000
Q2 2023 Jul 21, 2023	BUY	$205.19 - $232.99 $101,569 - $115,330	495 Added 20.54%	2,905 $641,000
Q1 2023 May 15, 2023	BUY	$212.99 - $276.17 $70,286 - $91,136	330 Added 15.87%	2,410 $539,000
Q4 2022 Feb 10, 2023	BUY	$205.95 - $280.43 $205,950 - $280,430	1,000 Added 92.59%	2,080 $578,000
Q3 2022 Nov 03, 2022	BUY	$203.3 - $244.17 $219,564 - $263,703	1,080 New	1,080 $226,000
Q2 2021 Aug 04, 2021	SELL	$170.47 - $211.93 $251,613 - $312,808	-1,476 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$153.94 - $174.85 $227,215 - $258,078	1,476 New	1,476 $247,000
Q3 2018 Oct 25, 2018	SELL	$113.81 - $129.46 $910,593 - $1.04 Million	-8,001 Closed	0 $0
Q2 2018 Jul 20, 2018	BUY	$101.14 - $118.31 $5,259 - $6,152	52 Added 0.65%	8,001 $905,000
Q1 2018 Apr 18, 2018	BUY	$107.21 - $151.94 $176,682 - $250,397	1,648 Added 26.15%	7,949 $893,000
Q4 2017 Jan 17, 2018	BUY	$118.58 - $151.28 $121,307 - $154,759	1,023 Added 19.38%	6,301 $932,000
Q3 2017 Oct 17, 2017	BUY	$114.6 - $136.81 $604,858 - $722,083	5,278	5,278 $619,000

Others Institutions Holding UTHR

# of Institutions

733

Shares Held

43.6M

Call Options Held

124K

Put Options Held

122K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $13.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning United Therapeutics Corp Transaction History